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Original Article
Diagnostic Value of Fine Needle Aspiration Cytology in Parotid Tumors
Muhammad Sohail Awan, Zafar Ahmad*
Departments of Surgery and ENT*, The Aga Khan University, Karachi and Fauji Foundation Hospital*, Rawalpindi.

Abstract
Objective: To evaluate the usefulness and accuracy of fine needle aspiration cytology in the diagnosis of parotid
gland tumors.
Methods: We reviewed files of all patients who underwent parotidectomy for various parotid pathologies at Aga
Khan University Hospital. Study design included a comparison between results of preoperative FNAC with final
histopathological diagnosis. Galen & Ganbino method was used to calculate sensitivity and specificity of FNAC.
Results: Among 50 patients reviewed, there was one false positive and 3 false negative results reported on
FNAC. This gives a sensitivity of FNAC for reporting malignancy to be 74% and specificity to rule out malignancy 97%. No significant complications were reported while performing the procedure.
Conclusion: FNAC is a safe and effective modality in diagnosis and treatment planning of patients with parotid
tumors (JPMA 54:617;2004).

Introduction
Parotid gland lesions are a histologically diverse
group. Tumours of this region comprise 3% of all head and
neck tumours and 0.6% of all tumours of human body.1
The role of fine needle aspiration cytology (FNAC)
for the diagnosis of salivary gland masses is well documented.The traditional open biopsy is no longer justified because
of risk of tumour spillage and damage to the facial nerve.2
FNAC on the other hand is safe, easy to perform, causes little discomfort to the patient and no risk of implantation of
tumour cells.3 Although the procedure has gained popularity, the fear of hemorrhage, facial nerve injury, as well as
lack of confidence in diagnostic accuracy have led clinicians to question the validity of FNAC in the management
of parotid lesions.4

We studied 50 patients who underwent parotid surgery for various parotid lesions to evaluate the usefulness
and accuracy of FNAC in the diagnosis of parotid gland
tumours.

Material and Methods
We reviewed files of all those patients undergoing
parotidectomy for various parotid pathologies between
January 1991 - December 2001 at Aga Khan University
Hospital. A total of 68 parotid resections were performed
during this time period. Of these, 50 patients were included
in the study in which preoperative FNAC and final histology slides were available for review.
FNAC was done by our pathology department using
a 22 gauge needle attached to a 10-ml syringe holder. A
minimum of two needle passes were made in each case. The

specimens were expelled onto two or three slides, and thin
smears were prepared between two slides and immediately
fixed. The slides were generally stained with Papanicolaou
and occasionally with May-Grunwald Giemsa (MGG)
methods.
FNAC results were classified into the following categories: true-negative (absence of malignancy correctly
diagnosed); true-positive (presence of malignancy correctly
diagnosed); false-negative (the cytological specimen failed
to diagnose a malignancy); and false-positive (the cytological specimen was incorrectly considered or suspect of
malignancy).
Study design included a comparison between results
of preoperative FNAC with final histopathological diagnoses. Data analysis was based on Galen and Gambino
method which calculates sensitivity and specificity of
FNAC in differentiating between benign and malignant
lesions (Table 1).
Table 1. Galan and Gambino method.
Sensitivity

a/a+c

Specificity

d / b + d x 100

Positive predictive value

a/a+b

x 100

Negative predictive value

d/c+d

x 100

Accuracy

a + d / a+b+c+d x 100

a

=

True +ve

b

=

False +ve

c

=

False -ve

d

=

True -ve

x 100

Results
Among 50 patients reviewed in this study 32 were
males and 18 female. Youngest patient in the series was 10
years of age and while the oldest one was 70 with a mean
age of 42 years. The results of FNAC showed that 42 cases
were diagnosed as benign and 8 were diagnosed as malignant. Among 42 benign reported on FNAC, 39 proved to be
benign on final histology, so there were 3 false negative
results reported on FNAC. FNAC reported 8 malignant
lesions but on final histopathology report 7 had a correct
diagnosis and there was one false positive (Table 2).

Table 2. False positive and false negative cases.
FNAC diagnosis

Histological diagnosis

Mucoepidermoid CA

Pleomorphic Adenoma

Pleomorphic Adenoma

Malignant Mixed Cell

Pleomorphic Adenoma

Mucoepidermoid CA

Oncocytoma

Metastatic Hepaticellular CA

tumour showed increase in swelling and pain after FNAC.
Hematoma, infection, facial nerve damage, implantation of
tumour cells, or other complications were not observed.

Discussion
The role of FNAC in the diagnosis of parotid tumors
has been well established as this is a safe and easy diagnostic procedure that causes little discomfort to the patient. The
main objective of FNAC in parotid lesions is to differentiate between benign lesions and malignant tumors. This
study reviews our experience with FNAC of parotid gland
tumors over a period of 10 years. Overall diagnostic accuracy was 92%, which compares well with other reports.5-7
Specificity of FNAC have been high, with false positive
being reported infrequently in the literature. In our series,
only one false positive has been reported and specificity
comes out to be 97%. The most common cause of a false
positive report is atypia in a benign mixed tumor.8
Sensitivity in our series is 70% which has varied in the literature from 64% to 99%.9 This results from percentages of
false-negatives which have been high in some studies.5,6
Such false-negatives may result from difficulty in distinguishing mucoepidermoid carcinoma from both Warthins
tumor and benign mixed tumor on a cytological smear.10
Errors can also be caused by confusion between benign
mixed tumor and adenoid cystic carcinoma.11

When Galen and Gambino method is applied this
gives 70% sensitivity of FNAC for reporting malignancy
and 97% specificity to rule out malignancy. The overall
accuracy in detecting malignant tumours was 92% with positive predictive and negative predictive values 87% and
92% respectively.

We have found FNAC specimens particularly useful
in the diagnosis of those tumors which are clinically unsuspected or clinically questionable parotid lesions. It is often
difficult even for the most experienced clinician to differentiate between tumors of the lower pole of the parotid and
high cervical swellings, such as enlarged upper jugular
chain lymph nodes or branchiogenic cysts. Reliability of
FNAC specimens in differentiating inflammatory conditions from tumors of parotid has previously been demonstrated.12 Ability to gain a correct diagnosis by FNAC in
such instances enables the surgeon to decide swiftly on
appropriate management, which otherwise would necessitate either a wait-and-see policy or open biopsy for diagnosis.

The FNAC was also evaluated for any complication
associated with the procedure. Two patients with Warthins

Complications of FNAC appear to be rare13,
although hematoma is occasionally reported.14 No morbidi-

morbidity was encountered in the 50 parotid needle
aspirations reported here except for one instance of increase
in size of swelling after FNAC in a patient with Warthins
tumor. An unusual complication of necrosis of a Warthins
tumor after FNAC was reported by Kern.15 Several authors
have commented specifically on the absence of any reported cases of tumor implantation at the site of FNAC.13,14,16,17
The danger of seeding of tumor cells in the needle tract or
in the puncture site in the skin remains a matter of concern
to those who are critical of this method of obtaining tissue
for diagnosis. Engzell et al18, found no recurrence involving
the skin or the site of the needle aspiration in 157 cases of
benign mixed tumors treated surgically and followed for 10
years. In another study, histological analysis of the excised
tumor area, including serial sections of the needle tract after
needle aspiration biopsy, also failed to reveal tumor seeding
in seven benign mixed tumors.8 Frable119 failed to observe
any recurrence in cases of pleomorphic adenoma. If there is
concern that the tumor cells may be implanted along the
needle tract, the puncture site can be tattooed and excised at
the time of surgery. This was done in a study by Qizilbash
et al.20 The histological examination of the excised needle
tract and puncture site in their study showed no evidence of
local implantation of tumor cells. However, the clinical significance of this is difficult to evaluate since the tumors
were excised along with the needle tract site of puncture
soon after the aspiration. No report of local tumor extension
caused by FNAC of the parotid is seen in our series. The use
of larger bore needles has led to this complication in other
sites, as well covered by Zajicek21 in his monograph.
Dissemination of tumor cells by vascular channels is a
potential danger of this technique. However, experiments in
rabbits suggest that needling the lesion does not result in
release of cancer cells into lymphatics and blood.18
The most important question to be answered by this
study is whether information gained by FNAC can be useful in management of patients. Our experience has demonstrated a variety of circumstances in which such information
may be valuable. The usual recommendation for neoplastic
lesions of the parotid regardless of the preoperative cytological diagnosis is excision but recognition of benign
lesions, particularly Warthins tumor, in poor risk patients
may be of benefit in avoiding inappropriate surgery.
Similarly, preoperative recognition of lymphoma may permit a simple operation to obtain tissue for typing than
parotidectomy with facial nerve dissection.4 FNAC may be
most advantageous in differentiating tumor from inflamma-

tion, for surgery may not be the treatment of choice. On the
other hand, preoperative recognition of malignancy may
help both surgeon and patient in terms of psychological,
medicolegal and surgical preparation.
FNAC is a safe and effective modality in diagnosis
and treatment planning of patients with parotid tumors. This
office procedure is reliable, easy to perform and cost effective and finally FNAC provides the surgeon with useful
information that otherwise could be obtained only by surgical exploration.
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